Other
Akralni melanom – prikaz 122 slučaja
Mladen Stanec
; Department of Surgical Oncology, University Hospital for Tumors, Zagreb, Croatia
Stjepan Juzbašić
; Department of Surgical Oncology, University Hospital for Tumors, Zagreb, Croatia
Miroslav Lesar
; Department of Surgical Oncology, University Hospital for Tumors, Zagreb, Croatia
Danko Velimir Vrdoljak
; Department of Surgical Oncology, University Hospital for Tumors, Zagreb, Croatia
Ivan Milas
; Department of Surgical Oncology, University Hospital for Tumors, Zagreb, Croatia
Nenad Nola
; Department of Surgical Oncology, University Hospital for Tumors, Zagreb, Croatia
Andrej Roth
; Department of Surgical Oncology, University Hospital for Tumors, Zagreb, Croatia
Dubravka Mužina
; Department of Surgical Oncology, University Hospital for Tumors, Zagreb, Croatia
Dubravka Krleža-Supić
; Department of Anesthesiology, University Hospital for Tumors, Zagreb,Croatia
Miroslav Banović
; Department of Transfusion Medicine and Hemostasis, University Hospital for Tumors, Zagreb, Croatia
Zrinko Petrinec
; Department of Surgical Oncology, University Hospital for Tumors, Zagreb, Croatia
Abstract
U radu su analizirana 122 bolesnika s akralnim melanomom ili oko 9,2% od 1.325 ukupno liječenih u Klinici za tumore u Zagrebu, od 1975 do 2002. Liječeno je 76 (62,3%) žena i 46 (37,7%) muškaraca prosječne dobi 58 godina. U 88 (72,1%) bolesnika tumor je bio na nogama, u 34 (27,9%) bolesnika na rukama, a među njima bilo je 15 (12,3%) ispod noktiju. Kirurško liječenje najčešće je uključivalo široku eksciziju primarnog tumora i plastiku, a kod melanoma ispod noktiju, amputaciju. U 35 (28,7%) bolesnika učinjena je disekcija klinički dokazanih metastaza u regionalnim limfnim čvorovima, a u 2 (1,6%) bolesnika učinjena je biospija sentinel čvora. Petogodišnje preživljenje u bolesnika stadija I i II bilo je 50%, a u stadiju III 20%.
Keywords
akralni melanom; kirurško liječenje; preživljenje
Hrčak ID:
281798
URI
Publication date:
3.12.2003.
Visits: 934 *